News

You’re considering new options for managing chronic pain, and PRP injections might just offer the relief you’re seeking. This innovative therapy taps into your body’s natural healing power, offering ...
PER-001, delivered through a slow-release, dissolvable implant in the vitreous cavity of the eye, is designed to block ...
The development of drug delivery platforms that offer sustained release of therapeutic agents in the retina represents a ...
Strategists weigh in on President Trump's shifting messaging on the Jeffrey Epstein files, enraging his MAGA base. 'Fridge cigarette' is Gen Z's new Diet Coke obsession that concerns health experts ...
Medicare does not cover platelet rich plasma injections for any health condition. Learn what you can expect to pay for them.
Vizz (Lenz Therapeutics) is the first and only aceclidine-based eye drop for presbyopia and is also the first daily solution to correct vision for up to 10 hours.
Researchers demonstrated that systemic factors from young mice can rejuvenate the aging retina by alleviating cellular senescence and restoring function.
The DRD Cure Accelerator, highlighted at the CCOI-Stanford Summit, is a global initiative advancing clinical research and ...
New study went head-to-head with HA vs. HA spiked with a little PRP magic. Spoiler alert: both help with pain.
Age-related macular degeneration (AMD), classified into dry and wet types, poses a significant threat to the vision of the elderly population globally. Despite its prevalence, the exact molecular ...
LX-101 is an adeno-associated-virus (AAV) gene therapy delivering a functional RPE65 gene directly to retinal cells, aiming to restore the visual cycle in patients with biallelic RPE65-mutation IRDs.
Retinal disorders can significantly impact vision and if left untreated can lead to serious and sometimes permanent vision impairment and blindness. Early detection and treatment are crucial for ...